Rationale: gamma -Aminobutyric acid (GABA) is the main inhibitory transmitt
er of the brain. The involvement of GABA(A) and GABA(B) receptors in sleep-
waking processes is well established. Objectives: This research studied the
influence of GABA(C) receptors. Methods: The rats were randomly infused in
the fourth ventricle with vehicle and 25, 50, and 100 mug (1,2,5,6,-tetrah
ydropyridine)-methylphosphinic acid (TPMPA), a specific antagonist of GABA,
receptors. Results: Principally at 50 mug, the molecule induced an increas
e of waking from 44.7% to 61.7% (P<0.003), which was the consequence of enh
ancement of both active and quiet wakefulness. Total slow wave sleep was de
creased, particularly the slow-wave stage from 39% to 27.7% (P<0.02). Parad
oxical sleep was also decreased from 14.5% to 9.1% (P<0.01). Conclusions: G
ABA(C) receptors are also involved in sleep-waking regulation. Since the se
nsitivity of GABA(C) receptors to GABA is much higher than that of GABA(A)
and GABA(B) receptors, GABA(C) receptor modulators could be potential medic
ations acting at low doses with fewer side effects.